NEWS | Release Therapeutics

All Posts
NEWS
EVENTS
PUBLICATIONS
AWARDS

1 hour ago1 min read

Release Tx Announces Scientific Advisory Board (SAB; 23 December 2024)

We are thrilled to introduce Release Tx's Scientific Advisory Board (SAB), which brings together leading experts in leukodystrophies,...

1 view0 comments

Nov 211 min read

Release Tx to attend 134th SICTIC Investor Day at IMD Lausanne (28 November 2024)

All of us at Release Tx are excited to be participating in the the 134th SICTIC Investor Day at IMD, Lausanne on 28 November 2024, where...

14 views0 comments

Nov 191 min read

Release Tx to attend Lenz & Staehelin Founders’ Evening (20 November 2024)

We’re pleased to announce that Release Therapeutics will be attending Founders’ Evening, organised by Lenz & Staehelin on 20 November at...

11 views0 comments

Nov 71 min read

Release Tx to attend Cell Press Tumor Immunology and Immunotherapy Symposium (11 – 12 November 2024)

We are pleased to announce that Release Tx will participate in the upcoming Cell Press LabLinks Tumor Immunology and Immunotherapy...

10 views0 comments

Oct 171 min read

Meet Release Tx at the ESGCT Congress in Rome (22–25 October 2024)

Release Therapeutics is pleased to announce our participation in the European Society of Gene and Cell Therapy (ESGCT) Congress that will...

11 views0 comments

Sep 251 min read

Meet Release Tx at FutureHealth Lausanne 2024 (1 October 2024)

Release Therapeutics is thrilled to announce our participation in FutureHealth Lausanne 2024, which kicks off at the SwissTech Convention...

23 views0 comments

Aug 62 min read

Release Therapeutics Secures CHF 3.3 Million in Seed Funding

The funding follows the Company’s first preclinical results in metachromatic leukodystrophy and will be invested in studies in non-human...

146 views0 comments

Jul 193 min read

Release Tx Announces Research Collaboration with Paris Brain Institute to Treat Metachromatic Leukodystrophy (MLD) and First Preclinical Results

We are thrilled to announce our strategic collaboration with Paris Brain Institute to explore the potential of our cutting-edge cell...

143 views0 comments

Jun 272 min read

Press Release: Release Therapeutics Announces New CEO to Drive Best-in-Class CNS Innovation

Release Tx Announces New CEO, aligning with the company’s recent pivot towards treating genetic disorders of the CNS without gene therapy

93 views0 comments

Jun 187 min read

Release Therapeutics publishes cutting-edge research in Cell Press

132 views0 comments

Jun 156 min read

Treating Genetic Disorders of the CNS without Gene Therapy (or what we’ve been up to here at Release Therapeutics)

Release Therapeutics' strategic pivot towards treating genetic disorders of the central nervous system without gene therapy.

155 views0 comments

Jun 141 min read

Meet us online at RESI Europe (18-19 June 2024)

Release Therapeutics is excited to announce our participation in the virtual partnering segment of RESI Europe, Barcelona from June...

6 views0 comments

Jan 131 min read

Meet us at the WORLDSymposium

Release Tx will join the 20th annual WORLDSymposium in San Diego. https://worldsymposia.org/

19 views0 comments

Oct 20, 20231 min read

Sustained delivery of low-dose anti-CTLA-4 by genetically engineered encapsulated cells drives tumor response and prolongs survival in a colorectal cancer model

AACR American Association for Cancer Research Orlando Florida Poster Grogg et al. 2023. iScience. Engineering a versatile and retrievable...

19 views0 comments

Sep 15, 20231 min read

MaxiVAX transitions into Release Tx

We are pleased to announce that, with the recent progress in the development of its unique platform technology, MaxiVAX is morphing into...

59 views0 comments

May 31, 20221 min read

Immortalized human myoblast cell lines for the delivery of therapeutic proteins using encapsulated cell technology

Molecular Therapy – Methods & Clinical Development Immortalized human myoblast cell lines for the delivery of therapeutic proteins using...

13 views0 comments

Jan 11, 20221 min read

Best Poster Awards 2022: Personalized immunotherapy with encapsulated cell technology

Best Poster Awards 2022 – ESMO conference – Our ECT technology as adjuvant to an au tologous cancer vaccine.

6 views0 comments

Jan 3, 20210 min read

Innovation Trophy 2021 - University of Geneva

2 views0 comments

Jan 11, 20171 min read

CTI Swiss Medtech Awards

Our ECT technology as adjuvant to an autologous cancer vaccine.

5 views0 comments